Archives

by in
Entry Author Date Location
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
The Missing Ingredient in Today’s Biotech: Guts 07/11/11 National
Immune Design Gets New CEO, Seattle Biomed Nabs $9M, VCs Turn Up Heat on FDA, & More Seattle-Area Life Sciences News 04/28/11 Seattle
Immune Design, Developer of New Vaccines, Adds Former Elan President as New CEO 04/27/11 Seattle
Q&A With Doug Williams: Reflecting on ZymoGenetics, Looking Ahead at Seattle Biotech 11/09/10 Seattle
ZymoGenetics CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move 11/08/10 Seattle
Immune Design Snags $212M Deal With MedImmune To Provide Vaccine Booster 10/26/10 Seattle
What Will Happen to ZymoGenetics’ Landmark Headquarters when Bristol Calls the Shots? 09/13/10 Seattle
Immune Design Follows Corixa Playbook, Sees Data, Deals on the Horizon in Year Three 07/27/10 Seattle
Immune Design Nabs $32M for Targeted Vaccines 07/26/10 Seattle
Burrill on How Dx Will Beat Rx, VCs Rip Into Pols, Tekmira Strikes Pfizer Deal, & More Seattle-Area Life Sciences News 03/18/10 Seattle
A Brief Year-End Review of Seattle Biotech 12/31/09 Seattle
Bezos Family Gives $10M to Hutch, Bruce Carter Back in the Saddle, Dendreon Deadline Set, & More Seattle-Area Life Sciences News 11/25/09 Seattle
So Much For Gardening: Bruce Carter Joins Vaccine Startup Immune Design To Raise Cash 11/23/09 Seattle
Novo Nordisk’s Historic Mistake is Seattle’s Future Gain, Says Novo CEO 09/18/09 Seattle
ZymoGenetics Plays Hardball, Asks FDA to Pull Competing Drug Off Market Because of Safety 08/20/09 Seattle
Johnson & Johnson, TB Alliance Form Partnership to Push New TB Drug Through Clinic 06/17/09 Seattle
Life Sciences on a Budget: Startups Make Pitch for Angel Dollars at First Zino Society Forum 02/25/09 Seattle
Hey, Don’t Forget the Puget Sound Life Sciences Universe! 02/09/09 Seattle
ZymoGenetics’ New Boss Sees Parallels to Dark Days at Immunex 01/05/09 Seattle
Seattle’s Top 10 Innovation Stories of the Half-Year (and Others We Just Plain Liked) 12/31/08 Seattle
Washington’s Life Sciences Ambassador, Jack Faris, Exits the Stage 12/29/08 Seattle
3Tier Group Gets $10M, Socialmedian Sold for $7.5M, Gates Gives $7M to IDRI, & More Seattle-Area Deals News 12/23/08 Seattle
Amgen Tries to “Personalize” Drug, VLST Snags Deal, Tobacco Money Backs Research, & More Seattle-Area Life Sciences News 12/18/08 Seattle
VLST Snags Partnership with Novo Nordisk to Develop New Drugs for Autoimmunity 12/17/08 Seattle
Luck, Curiosity, Naivete: The Essential Ingredients of Innovation 12/16/08 Seattle
Bruce Carter Exits Stage Left, Targeted Genetics Cuts Payroll, OncoGenex Cancer Drug Prolongs Lives, & More Seattle-Area Life Sciences News 12/04/08 Seattle
ZymoGenetics CEO Bruce Carter Retires, Promotes Doug Williams, Says Sad Goodbyes to Biotech “Family” 11/21/08 Seattle
WBBA Hires Chris Rivera As President, Replacing Retiring Jack Faris 11/19/08 Seattle
ZymoGenetics “Sleeper” for Hepatitis C Aims to Wipe Out Side Effects of Anti-Viral Therapy 09/30/08 Seattle
Page 1 of 2 next page »